Many Duchenne muscular dystrophy patients in the U.S. have imported a medicine called deflazacort for about $1,200 a year. A brand-name version just approved for sale in America costs $89,000.
A federal judge issued a preliminary injunction barring the government from enforcing a rule allowing insurers to refuse to insure dialysis patients who get financial assistance from charity groups.
A study tracking depression rates among U.S. teens from 2005 to 2014 finds an increase — especially among girls. A steady diet of harsh judgments from social media may play a role, researchers say.
The stroke left Christine Hyung-Oak Lee unable remember things for more than 15 minutes. As she slowly got better, she was surprised to find that grief and recovery were inextricably linked.
Men and women experience some diseases differently. Doctor Paula Johnson says this is alarming — because most treatments were designed for men, not women.
Doctors often take a patient's race into account when making a diagnosis--or ruling one out. Professor Dorothy Roberts says this practice is both outdated and dangerous.
Doctors told Jen Brea that her symptoms were psychosomatic, so she filmed herself and turned to the Internet for guidance. She describes how her online community helped her find the right diagnosis.
Once a staple in India, millets have fallen out of fashion in recent years. Now, faced with water shortages, one Indian state is re-introducing these drought tolerant cereals to people's diets.
Uncertainty about the fate of the Affordable Care Act has created a "nightmare scenario" for health insurers as they try to determine what to charge for coverage in 2018.